Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 170

    1.

    ALLHAT: setting the record straight.

    Davis BR, Furberg CD, Wright JT Jr, Cutler JA, Whelton P; ALLHAT Collaborative Research Group.

    Ann Intern Med. 2004 Jul 6;141(1):39-46. Review.PMID: 15238369 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A family physician questions the conclusions from ALLHAT.

    Standridge JB.

    Am J Hypertens. 2004 Apr;17(4):361-5. Review.PMID: 15062891 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications.

    Oparil S.

    Hypertension. 2003 May;41(5):1006-9. Epub 2003 Apr 14. No abstract available. PMID: 12695423 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

    Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM.

    Am J Hypertens. 1996 Apr;9(4 Pt 1):342-60.PMID: 8722437 [PubMed - indexed for MEDLINE]Related articles

    5.

    [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]]

    Tomiyama H, Doba N.

    Nippon Rinsho. 2001 Mar;59 Suppl 3:393-7. Review. Japanese. No abstract available. PMID: 11347101 [PubMed - indexed for MEDLINE]Related articles

    6.

    ALLHAT in perspective: implications to clinical practice and clinical trials.

    Yusoff K.

    Med J Malaysia. 2005 Jun;60(2):239-45. Review.PMID: 16114170 [PubMed - indexed for MEDLINE]Related articles

    7.

    ALLHAT, or the soft science of the secondary end point.

    Messerli FH.

    Ann Intern Med. 2003 Nov 4;139(9):777-80.PMID: 14597462 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.
    9.

    Experimental approaches to determining the choice of first-step therapy for patients with hypertension. The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

    Whelton PK, Williamson JD, Louis GT, Davis BR, Cutler JA.

    Clin Exp Hypertens. 1996 Apr-May;18(3-4):569-79. Review.PMID: 8743044 [PubMed - indexed for MEDLINE]Related articles

    10.

    Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

    Black HR, Davis B, Barzilay J, Nwachuku C, Baimbridge C, Marginean H, Wright JT Jr, Basile J, Wong ND, Whelton P, Dart RA, Thadani U; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

    Diabetes Care. 2008 Feb;31(2):353-60. Epub 2007 Nov 13.PMID: 18000186 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experience.

    Wright JT Jr, Cushman WC, Davis BR, Barzilay J, Colon P, Egan D, Lucente T, Nwachuku C, Pressel S, Leenen FH, Frolkis J, Letterer R, Walsh S, Tobin JN, Deger GE; ALLHAT Research Group.

    Control Clin Trials. 2001 Dec;22(6):659-73.PMID: 11738122 [PubMed - indexed for MEDLINE]Related articles

    12.

    ALLHAT: a critical assessment.

    Sjöholm A.

    Blood Press. 2004;13(2):75-9.PMID: 15182109 [PubMed - indexed for MEDLINE]Related articles

    13.

    The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort.

    Hebert LA, Rovin BH, Hebert CJ.

    Nat Clin Pract Nephrol. 2007 Feb;3(2):60-1. No abstract available. PMID: 17251990 [PubMed - indexed for MEDLINE]Related articles

    14.

    The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Heart Failure Validation Study: diagnosis and prognosis.

    Einhorn PT, Davis BR, Massie BM, Cushman WC, Piller LB, Simpson LM, Levy D, Nwachuku CE, Black HR; ALLHAT Collaborative Research Group.

    Am Heart J. 2007 Jan;153(1):42-53.PMID: 17174636 [PubMed - indexed for MEDLINE]Related articles

    15.

    ALLHAT, or the soft science of the secondary end point.

    Neely DB.

    Ann Intern Med. 2004 Jul 6;141(1):77. No abstract available. PMID: 15238380 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Guidelines for antihypertensive treatment: an update after the ALLHAT study.

    Salvetti A, Ghiadoni L.

    J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S51-4. Review.PMID: 14684673 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hypertension and atherosclerosis: clinical implications from the ALLHAT Trial.

    Standridge JB.

    Curr Atheroscler Rep. 2005 Mar;7(2):132-9. Review.PMID: 15727729 [PubMed - indexed for MEDLINE]Related articles

    18.

    Metabolic issues in the Antihypertensive and Lipid-Lowering Heart Attack Trial Study.

    Punzi HA, Punzi CF; Antihypertensive and Lipid-Lowering Heart Attack Trial Study; Trinity Hypertension Research Institute.

    Curr Hypertens Rep. 2004 Apr;6(2):106-10. Review.PMID: 15010012 [PubMed - indexed for MEDLINE]Related articles

    19.

    A comparison between persistence to therapy in ALLHAT and in everyday clinical practice: a generalizability issue.

    Cardinal H, Monfared AA, Dorais M, LeLorier J.

    Can J Cardiol. 2004 Mar 15;20(4):417-21. Review.PMID: 15057318 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.

    Berecek KH, Farag A, Bahtiyar G, Rothman J, McFarlane SI.

    Curr Hypertens Rep. 2004 Jun;6(3):212-4. No abstract available. PMID: 15128474 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data